Structure: A Lot Riding On Next Data Readout For Oral GLP-1 Candidate
Despite a crowded GLP-1 drug development field, Structure's oral small molecule approach and strong financial position offer ...
Medscape12y
GLP-1 and GLP-2 as Yin and Yang of Intestinal Lipoprotein Production
The glucagon-like peptides (GLP-1 and GLP-2) are processed from the proglucagon polypeptide and secreted in equimolar amounts but have opposite effects on chylomicron (CM) production, with GLP-1 ...
The Rocky Mountain Collegian7d
Liraglutide Peptide: Unveiling Its Potential Implications in Scientific Research
Liraglutide is a peptide that has gained significant attention in scientific research due to its structural similarity to ...
Hosted on MSN1mon
GLP-1 Receptor Agonists for Diabetes Tied to Slightly Lower Depression Risk
Guo and co-authors found no evidence of significant interaction in a subgroup analysis stratified by age, sex, race and ethnicity, obesity, insulin use, or molecular structure of GLP-1 agonist ...
UBS4mon
GLP-1: A medication worth $126 billion in sales by 2029?
The uptake of GLP-1 has surged since 2022, mainly in US. Read our takeaways from the UBS Evidence Lab survey on key trends in GLP-1 consumer behaviour GLP-1s, also known as glucagon-like peptide 1, ...
C&EN11d
Improving GLP-1 drug delivery by ‘painting’ it on antibodies
SAN DIEGO, March 23, 2025 — Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics ... present his team’s results at the spring meeting of the American Chemical Society (ACS) ...